Amiodarone-associated optic neuropathy: A critical review

American Journal of Medicine

Volumn 125, Issue 5, 2012, Pages 447-453

  Passman, Rod S ^a   Bennett, Charles L ^b   Purpura, Joseph M ^a   Kapur, Rashmi ^c   Johnson, Lenworth N ^d   Raisch, Dennis W ^e   West, Dennis P ^a,f   Edwards, Beatrice J ^g   Belknap, Steven M ^a,f   Liebling, Dustin B ^g   Fisher, Mathew J ^g   Samaras, Athena T ^f   Jones, Lisa Gaye A ^h   Tulas, Katrina Marie E ^g   McKoy, June M ^a,g  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f Department of Dermatology ^*  (United States)

^g Division of Geriatric Medicine   (United States)

^h UNIVERSITY OF IOWA   (United States)

Author keywords

Amiodarone; Optic neuropathy; Vision loss

Indexed keywords

AMIODARONE;

BLINDNESS; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; OPTIC NERVE DISEASE; PAPILLEDEMA; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; BLINDNESS; HUMANS; OPTIC NERVE DISEASES;

EID: 84859501182     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.09.020     Document Type: Review

References (68)

1. M.C. Fang, R.S. Stafford, J.N. Ruskin, D.E. Singer National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation Arch Intern Med 164 1 2004 55 60
2. IMS Heath, Inc IMS Health National Disease and Therapeutic Index 2010 IMS Heath, Inc. Plymouth Meeting, PA
3. D. Roy, M. Talajic, P. Dorian Amiodarone to prevent recurrence of atrial fibrillation Canadian Trial of Atrial Fibrillation Investigators N Engl J Med 342 13 2000 913 920
4. B.N. Singh, S.N. Singh, D.J. Reda Amiodarone versus Sotalol for atrial fibrillation N Engl J Med 352 18 2005 1861 1872
5. E.A. Raeder, P.J. Podrid, B. Lown Side effects and complications of amiodarone therapy Am Heart J 109 5 Pt 1 1985 975 983
6. S.R. Punnam, S.K. Goyal, V.P. Kotaru, A.R. Pachika, G.S. Abela, R.K. Thakur Amiodarone - a 'broad spectrum' antiarrhythmic drug Cardiovasc Hematol Disord Drug Targets 10 1 2010 73 81
7. H. Rehman Amiodarone for atrial fibrillation N Engl J Med 356 23 2007 2424 2426 author reply 2426
8. P. Vassallo, R.G. Trohman Prescribing amiodarone: an evidence-based review of clinical indications Jama 298 11 2007 1312 1322
9. L.N. Johnson, G.B. Krohel, E.R. Thomas The clinical spectrum of amiodarone-associated optic neuropathy J Natl Med Assoc 96 11 2004 1477 1491
10. M.E. Charness, F. Morady, M.M. Scheinman Frequent neurologic toxicity associated with amiodarone therapy Neurology 34 5 1984 669 671
11. D.P. Zipes, P. Libby, R.O. Bonow, E. Braunwald Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine 7th ed. 2005 WB Saunders Philadelphia, PA
12. H.T. Stelfox, S.B. Ahmed, J. Fiskio, D.W. Bates Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice Clin Pharmacol Ther 75 1 2004 110 122
13. D.C. Macaluso, W.T. Shults, F.T. Fraunfelder Features of amiodarone-induced optic neuropathy Am J Ophthalmol 127 5 1999 610 612
14. L.A. Feiner, B.R. Younge, F.J. Kazmier Optic neuropathy and amiodarone therapy Mayo Clin Proc 62 8 1987 702 717
15. N. Goldschlager, A.E. Epstein, G. Naccarelli Practical guidelines for clinicians who treat patients with amiodarone Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology Arch Intern Med 160 12 2000 1741 1748
16. Wyeth Dear Patient Letter http://www.fda.gov/downloads/Safety/MedWatch/ SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM164421.pdf Dec 2004 Accessed July 19, 2011
17. L. Lee, C. Kortepeter, M. Willy, P. Nourjah Drug-risk communication to pharmacists: assessing the impact of risk-minimization strategies on the practice of pharmacy J Am Pharm Assoc 48 4 2003 494 500
18. V. Purvin, A. Kawasaki, F.X. Borruat Optic neuropathy in patients using amiodarone Arch Ophthalmol 124 5 2006 696 701
19. J.C. Rucker, V. Biousse, N.J. Newman Ischemic optic neuropathies Curr Opin Neurol 17 1 2004 27 35
20. L.N. Johnson, A.C. Arnold Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy Population-based study in the state of Missouri and Los Angeles County, California J Neuroophthalmol 14 1 1994 38 44
21. L.N. Johnson, M.E. Guy, G.B. Krohel, R.W. Madsen Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy Ophthalmology 107 3 2000 521 526
22. R.W. Beck, G.E. Servais, S.S. Hayreh Anterior ischemic optic neuropathy IX. Cup-to-disc ratio and its role in pathogenesis Ophthalmology 94 11 1987 1503 1508
23. R.M. Burde Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy Am J Ophthalmol 116 6 1993 759 764
24. C.L. Bennett, J.R. Nebeker, E.A. Lyons The Research on Adverse Drug Events and Reports (RADAR) project Jama 293 17 2005 2131 2140
25. M.H. Samore, R.S. Evans, A. Lassen Surveillance of medical device-related hazards and adverse events in hospitalized patients Jama 291 3 2004 325 334
26. D. Miller, P.C. Magnante Optics of the normal eye M. Yanoff, J.S. Duker, Ophthalmology 2nd ed. 2004 Mosby St. Louis, MO 53
27. S.J. Evans, P.C. Waller, S. Davis Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports Pharmacoepidemiol Drug Saf 10 6 2001 483 486
28. W. DuMouchel, E.T. Smith, R. Beasley Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data Clin Ther 26 7 2004 1092 1104
29. J.R. Curtis, H. Cheng, E. Delzell Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example Med Care 46 9 2008 969 975
30. M. Van Zandijcke, A. Dewachter Pseudotumor cerebri with amiodarone J Neurol Neurosurg Psychiatry 49 12 1986 1463 1464
31. F.X. Borruat, F. Regli Pseudotumor cerebri as a complication of amiodarone therapy Am J Ophthalmol 116 6 1993 776 777
32. S. Almog, N. Shafran, H. Halkin Mechanism of warfarin potentiation by amiodarone: dose - and concentration - dependent inhibition of warfarin elimination Eur J Clin Pharmacol 28 3 1985 257 261
33. T. Eryilmaz, H. Atilla, F. Batioglu, I. Gunalp Amiodarone-related optic neuropathy Jpn J Ophthalmol 44 5 2000 565 568
34. R.R. Seemongal-Dass, S.R. Spencer Bilateral optic neuropathy linked with amiodarone Eye (Lond) 12 Pt 3a 1998 474 477
35. P. Palimar, N. Cota Bilateral anterior ischaemic optic neuropathy following amiodarone Eye (Lond) 12 Pt 5 1998 894 896
36. S.M. Nazarian, W.M. Jay Bilateral optic neuropathy associated with amiodarone therapy J Clin Neuroophthalmol 8 1 1988 25 28
37. L.A. Sedwick Getting to the heart of visual loss: when cardiac medication may be dangerous to the optic nerves Surv Ophthalmol 36 5 1992 366 372
38. M.A. Speicher, M.H. Goldman, G.A. Chrousos Amiodarone optic neuropathy without disc edema J Neuroophthalmol 20 3 2000 171 172
39. D.D. Castells, B.A. Teitelbaum, D.J. Tresley Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy Optometry 73 2 2002 113 121
40. P.K. Nagra, R. Foroozan, P.J. Savino Amiodarone induced optic neuropathy Br J Ophthalmol 87 4 2003 420 422
41. A.G. Sreih, M.H. Schoenfeld, M.A. Marieb Optic neuropathy following amiodarone therapy Pacing Clin Electrophysiol 22 7 1999 1108 1110
42. J.W. Gittinger Jr, G.K. Asdourian Papillopathy caused by amiodarone Arch Ophthalmol 105 3 1987 349 351
43. J.L. Ferreiro, J.A. Isern Longares, A.F. Ramon Moya Optic neuropathy caused by amiodarone Neurologia 5 5 1990 160 163
44. P. Krieg, I. Schipper Bilateral optic neuropathy following amiodarone therapy Klin Monbl Augenheilkd 200 2 1992 128 132
45. L. Belec, G. Davila, J.M. Bleibel Bilateral optic neuropathy during prolonged treatment with amiodarone Ann Med Interne (Paris) 143 5 1992 349 350
46. J. Bartolucci, P. Ibanez, C. Verdugo Amiodarone induced retrobulbar neuritis Clinical case Rev Med Chil 127 7 1999 827 830
47. R. Gobbele, C. Dahlke, M. Mull, M. Schwarz Amiodarone-induced bilateral optic atrophy - a case report Nervenarzt 70 6 1999 560 565
48. D. Leifert, L.L. Hansen, J. Gerling Amiodarone-associated optic neuropathy: an independent syndrome? Three patients with bilateral optic neuropathy Klin Monbl Augenheilkd 217 3 2000 171 177
49. N. Kristin, M. Ulbig Acute papilledema A 69-year-old patient with acute bilateral papilledema Ophthalmologe 98 2 2001 212 213
50. B.C. Polak, P.A. Tutein Nolthenius, E. Rietveld Visual impairment due to optic neuropathy in 2 patients on amiodarone therapy, i.e. ethambutol and isoniazide Ned Tijdschr Geneeskd 145 19 2001 922 926
51. C.A. Uebermuth, E. Gerke First unilateral, later bilateral optic neuropathy Amiodarone as the cause? Ophthalmologe 99 6 2002 470 473
52. B.G. Fikkers, J. Bogousslavsky, F. Regli, S. Glasson Pseudotumor cerebri with amiodarone J Neurol Neurosurg Psychiatry 49 5 1986 606
53. W.A. Grogan, D.M. Narkun Pseudotumor cerebri with amiodarone J Neurol Neurosurg Psychiatry 50 5 1987 651
54. D. Schmidt Amiodarone treatment and visual prognosis Klin Monbl Augenheilkd 220 11 2003 774 786
55. F. Ait Ali, F. Grolleau-Raoux, B. Arnaud, C.F. Schmitt-Bernard Amiodarone and disk edema: physiopathological debate based on a case report J Fr Ophtalmol 26 2 2003 182 186
56. M.F. Domingues, H. Barros, F.M. Falcao-Reis Amiodarone and optic neuropathy Acta Ophthalmol Scand 82 3 Pt 1 2004 277 282
57. D.W. Holt, G.T. Tucker, P.R. Jackson, G.C. Storey Amiodarone pharmacokinetics Am Heart J 106 4 Pt 2 1983 840 847
58. J.S. Mindel, J. Anderson, A. Hellkamp Absence of bilateral vision loss from amiodarone: a randomized trial Am Heart J 153 5 2007 837 842
59. A.M. Mansour, J.E. Puklin, R. O'Grady Optic nerve ultrastructure following amiodarone therapy J Clin Neuroophthalmol 8 4 1988 231 237
60. J.M. Abarbanel, A. Osiman, S. Frisher, Y. Herishanu Peripheral neuropathy and cerebellar syndrome associated with amiodarone therapy Isr J Med Sci 23 8 1987 893 895
61. J.M. Jacobs, F.R. Costa-Jussa The pathology of amiodarone neurotoxicity II. Peripheral neuropathy in man Brain 108 Pt 3 1985 753 769
62. M. Mantyjarvi, K. Tuppurainen, K. Ikaheimo Ocular side effects of amiodarone Surv Ophthalmol 42 4 1998 360 366
63. W. Yamreudeewong, M. DeBisschop, L.G. Martin, D.L. Lower Potentially significant drug interactions of class III antiarrhythmic drugs Drug Saf 26 6 2003 421 438
64. N. Venkatesh, B.N. Singh, L. Al-Sarraf, R. Kannan Digoxin- desethylamiodarone interaction in the rat: comparison with the effects of amiodarone J Cardiovasc Pharmacol 8 2 1986 309 313
65. I.G. Rennie Clinically important ocular reactions to systemic drug therapy Drug Saf 9 3 1993 196 211
66. G.J. Barron, L. Tepper, G. Iovine Ocular toxicity from ethambutol Am J Ophthalmol 77 2 1974 256 260
67. U. Kim, J.M. Hwang Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography Eur J Ophthalmol 19 3 2009 466 469
68. National Institute for Health and Clinical Excellence Atrial fibrillation: the management of atrial fibrillation; Clinical guideline 36 (CG36); 2006 [cited 2010 April 21] http://www.nice.org.uk/nicemedia/pdf/ CG036niceguideline.pdf Accessed August 8, 2011